Last $0.16 USD
Change Today +0.0003 / 0.16%
Volume 34.3K
VASO On Other Exchanges
Symbol
Exchange
OTC US
As of 8:10 PM 03/5/15 All times are local (Market data is delayed by at least 15 minutes).

vasomedical inc (VASO) Snapshot

Open
$0.17
Previous Close
$0.16
Day High
$0.17
Day Low
$0.16
52 Week High
03/26/14 - $0.50
52 Week Low
12/15/14 - $0.14
Market Cap
25.6M
Average Volume 10 Days
33.6K
EPS TTM
$-0.0070
Shares Outstanding
155.7M
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for VASOMEDICAL INC (VASO)

Related News

No related news articles were found.

vasomedical inc (VASO) Related Businessweek News

No Related Businessweek News Found

vasomedical inc (VASO) Details

Vasomedical, Inc. designs, manufactures, markets, and supports enhanced external counterpulsation (EECP) systems, ambulatory monitoring systems, and other medical equipment. Its EECP therapy is used for the treatment of chronic stable angina and congestive heart failure, as well as for acute myocardial infarction, and cardiogenic shock. The company also offers in-service and training support for the EECP systems; and distributes GEHC diagnostic imaging products. The company offers its products and services to treatment providers, such as hospitals, clinics, and physician private practices through sales managers in the United States; and a network of independent distributors internationally. Vasomedical, Inc. was founded in 1987 and is headquartered in Westbury, New York.

215 Employees
Last Reported Date: 03/27/14
Founded in 1987

vasomedical inc (VASO) Top Compensated Officers

Chief Executive Officer, President and Direct...
Total Annual Compensation: $375.0K
Chief Financial Officer and Secretary
Total Annual Compensation: $200.0K
Senior Vice President, Chief Executive Office...
Total Annual Compensation: $600.0K
Vice President of Finance, Controller and Tre...
Total Annual Compensation: $165.0K
Compensation as of Fiscal Year 2013.

vasomedical inc (VASO) Key Developments

Vasomedical Inc. Announces Auditor Changes

At a meeting held on December 9, 2014, the Audit Committee of Vasomedical Inc. approved the engagement of Marcum LLP as its independent registered public accounting firm for the fiscal year ending December 31, 2014, subject to their approval. Marcum accepted this engagement on December 12, 2014, at which time the company's prior independent registered public accounting firm, KPMG LLP, was dismissed.

Vasomedical Inc. Announces Earnings Results for the Third Quarter and Nine Months Ended September 30, 2014

Vasomedical Inc. announced earnings results for the third quarter and nine months ended September 30, 2014. For the quarter, revenue was $7,643,000 against $7,606,000 a year ago. Operating loss was $149,000 against $492,000 a year ago. Loss before taxes was $97,000 against $555,000 a year ago. Net loss was $123,000 against $464,000 a year ago. The decrease in the loss is principally due to the increase in gross profit from sales representation segment partially offset by a decrease in the gross profit in Equipment segment. For the nine months, revenue was $22,599,000 against $22,795,000 a year ago. Operating loss was $1,443,000 against $1,704,000 a year ago. Loss before taxes was $1,293,000 against $1,684,000 a year ago. Net loss was $1,343,000 against $1,649,000 a year ago.

Vasomedical Inc. to Report Q3, 2014 Results on Nov 12, 2014

Vasomedical Inc. announced that they will report Q3, 2014 results at 10:00 AM, US Eastern Standard Time on Nov 12, 2014

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
VASO:US $0.16 USD +0.0003

VASO Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Hologic Inc $32.44 USD +0.08
Koninklijke Philips NV €26.82 EUR +0.155
Siemens AG €99.26 EUR -0.153
Toshiba Corp ¥487.40 JPY +2.40
View Industry Companies
 

Industry Analysis

VASO

Industry Average

Valuation VASO Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 0.8x
Price/Book 4.9x
Price/Cash Flow NM Not Meaningful
TEV/Sales 0.5x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact VASOMEDICAL INC, please visit www.vasomedical.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.